Pain in patient with preeclampsia and eclampsia receiving intramuscular magnesium sulphate.
Conditions
Interventions
Two injection method
One Injection
Sponsors
University of Botswana
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patient with preeclampsia or eclampsia receiving magnesium sulphate Client willing and consenting to take part in the study Conscious, able to give consent and give answers to questions about pain and preference
Exclusion criteria
Exclusion criteria: Age less than 18 years (consenting age ) critically ill patient (very sick, unstable or unconscious patient, GCS <13 or haemo-dynamically unstable patient) Allergic to magnesium sulphate or lignocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Verbal report on perceived pain after the injection using using numeric pain scale of 1-10 where 0 is no pain and 10 is unbearable pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Preferred method of injection in the future, that is either one injection or two injection method ;Most painful method of injection ;Reason for the preferred future method of injection administration ;Verbal report on perceived pain after receiving intramuscular injection using simple descriptive words that is no pain, mild pain, severe pain and unbearable pain and also | — |
Countries
Botswana
Contacts
Public ContactRebecca Luckett
Department of Obstetrics and gynaecology Faculty of Medicine University of Botswana and Department of Obstetrics and gynaecology Princess Marina Hospital Gaborone Botswana
Outcome results
None listed